Brain Fog: What Could Be Causing It and How to Fix It

What Exactly Is Brain Fog?

Brain fog describes a cluster of cognitive complaints: difficulty concentrating, slower-than-usual thinking, word-finding problems, and a persistent sense of mental fatigue. Patients often describe it as "thinking through cotton wool." It is not a formal ICD-10 diagnosis, but it signals that something in the body is interfering with normal neurological function.

The term appears in research literature across neurology, endocrinology, and psychiatry without a single standardized definition. A 2022 review in Nature Reviews Neuroscience described post-COVID cognitive impairment in terms of "reduced speed of processing, impaired sustained attention, and working-memory deficits," which maps well onto what most patients call brain fog. [1]

Because brain fog is symptom-based rather than disease-specific, clinicians work through a differential diagnosis rather than treating the label itself.

Why the Differential Matters

Starting treatment before identifying the cause wastes time and can mask serious conditions. A 60-year-old with new-onset memory slowing needs a different first step than a 32-year-old perimenopausal woman reporting word-finding gaps. Age, sex, symptom onset (sudden vs. Gradual), and accompanying symptoms all shape the workup.

How Common Is It?

Population-level data are difficult to pin down because the symptom goes by many names in different disease cohorts. A 2021 survey of 3,762 adults with long COVID conducted by the Patient-Led Research Collaborative found that 88% reported brain fog as one of their most disabling symptoms. [2] Outside the post-COVID context, chronic fatigue syndrome and fibromyalgia cohorts report cognitive complaints in 50 to 80% of patients. [3]

The Most Common Causes of Brain Fog

Sleep Deprivation and Sleep Disorders

Sleep is the single most reversible cause. The CDC recommends at least 7 hours of sleep per night for adults, and data from the 2020 National Health Interview Survey found that 14.5% of U.S. Adults reported trouble falling asleep most days. [4] Even mild restriction to 6 hours per night over two weeks produces cognitive deficits equivalent to two full nights of total sleep deprivation in controlled laboratory conditions. [5]

Obstructive sleep apnea (OSA) is a separate, often undiagnosed cause. OSA produces intermittent hypoxia that directly impairs prefrontal cortex function. The Wisconsin Sleep Cohort found that moderate-to-severe OSA (AHI > 15) was present in approximately 13% of men and 6% of women aged 30 to 70. [6]

Clinical takeaway: Before ordering extensive labs, ask about sleep duration, snoring, witnessed apneas, and morning headaches.

Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism impair cognition, though hypothyroidism is far more commonly missed. The American Thyroid Association estimates that 20 million Americans have some form of thyroid disease, and up to 60% are undiagnosed. [7]

Subclinical hypothyroidism, defined as a TSH between 4.5 and 10 mIU/L with normal free T4, produces measurable cognitive slowing in some but not all patients. A 2019 Cochrane review of levothyroxine for subclinical hypothyroidism (10 trials, N>1,200) found no significant cognitive benefit in older adults, but individual response varies and symptomatic younger patients often do improve with treatment. [8]

TSH, free T4, and free T3 are the minimum starting point. Thyroid peroxidase antibodies (anti-TPO) are worth ordering if Hashimoto's thyroiditis is suspected.

Hormonal Changes: Estrogen, Progesterone, and Testosterone

Estrogen has direct effects on synaptic density, acetylcholine synthesis, and cerebral glucose metabolism. As estrogen drops in perimenopause and menopause, many women report what the Menopause Society (formerly NAMS) describes as "difficulty with verbal memory and the ability to learn new information." [9]

The SWAN (Study of Women's Health Across the Nation) followed 2,362 women through the menopausal transition and found that processing speed and verbal memory declined most sharply in the late perimenopause stage, not after the final menstrual period. [10] This timing matters clinically: women who come in during late perimenopause with cognitive complaints are often told "you are not yet menopausal" and sent away without treatment.

Testosterone plays a parallel role in men and women. In men, hypogonadism (total testosterone <300 ng/dL per Endocrine Society guidelines) is associated with reduced working memory, spatial ability, and verbal fluency. A 2020 meta-analysis in JAMA Network Open covering 8 randomized controlled trials (N=1,252) found that testosterone therapy in hypogonadal men improved spatial memory scores compared to placebo. [11]

In women, testosterone concentrations decline by roughly 50% between age 20 and 45, and low free testosterone has been associated with fatigue and cognitive complaints in observational data, though randomized trial evidence in women remains thinner.

Insulin Resistance and Blood Sugar Dysregulation

The brain consumes roughly 20% of the body's glucose despite accounting for only 2% of body weight. [12] Insulin resistance impairs cerebral glucose uptake through reduced GLUT4 and GLUT1 transporter activity, and this effect is detectable even before a type 2 diabetes diagnosis.

The Whitehall II cohort study (N=10,308) found that adults with HbA1c in the prediabetic range (5.7 to 6.4%) showed faster cognitive decline over 10 years compared to those with normal HbA1c. [13] A fasting glucose, HbA1c, and a fasting insulin level (to calculate HOMA-IR) can identify insulin resistance before it progresses.

Nutritional Deficiencies

Vitamin B12. Deficiency is strongly associated with cognitive symptoms through impaired myelin synthesis and elevated homocysteine. Serum B12 <200 pg/mL is clearly deficient; the 200 to 300 pg/mL range is a gray zone where methylmalonic acid levels can clarify true tissue deficiency. Vegetarians, vegans, adults over 60, and patients on metformin (which blocks B12 absorption) are at highest risk.

Vitamin D. A cross-sectional analysis of NHANES data (N=5,648) found that adults with serum 25-OH vitamin D <20 ng/mL scored significantly lower on cognitive tests, including attention and processing speed, compared to those with levels above 30 ng/mL. [14]

Ferritin and iron. Iron deficiency, even without overt anemia, affects dopamine synthesis. Ferritin <30 ng/mL is associated with fatigue and cognitive symptoms, particularly in menstruating women. Replenishing iron in iron-deficient non-anemic women has improved fatigue scores in randomized data.

Omega-3 fatty acids. DHA is a structural component of neuronal membranes. Observational data link low EPA+DHA erythrocyte levels to faster cognitive aging, though intervention trials in healthy middle-aged adults have not uniformly shown benefit.

Long COVID and Post-Viral Cognitive Impairment

Long COVID is now one of the leading causes of new-onset brain fog in the 18 to 60 age bracket. A large prospective cohort study of 273,618 COVID-19 survivors published in The Lancet Psychiatry found that 22% had at least one neurological or psychiatric diagnosis within 6 months of infection, with cognitive deficit present in approximately 4% as a primary diagnosis. [15]

The proposed mechanisms include neuroinflammation, microglial activation, mitochondrial dysfunction, and microvascular endothelial injury. No single biomarker has been validated for clinical use, but elevated inflammatory markers (CRP, ferritin, IL-6) are commonly seen.

Current management is supportive, focusing on paced activity, sleep optimization, and treatment of contributing factors (low ferritin, vitamin D insufficiency, hypothyroidism). A 2023 clinical guidance statement from the Infectious Diseases Society of America recommends against aggressive aerobic exercise in the early post-COVID phase because of post-exertional malaise risk.

Mood Disorders: Depression and Anxiety

Depression is the single largest psychiatric cause of cognitive complaints. The DSM-5 criteria for major depressive disorder include "diminished ability to think or concentrate" as a core symptom. In an analysis of 22 randomized trials covering 4,000 patients with MDD, cognitive performance improved significantly with remission of depressive symptoms, confirming that cognitive dysfunction in depression is partially state-dependent. [16]

Anxiety produces brain fog through a different pathway. Chronic activation of the HPA axis elevates cortisol, which is directly neurotoxic to the hippocampus at sustained high levels. The Nurses' Health Study II found that women with the highest self-reported stress scores showed hippocampal volume reductions on MRI compared to low-stress controls.

Screening tools: PHQ-9 for depression (score >4 warrants further assessment), GAD-7 for generalized anxiety.

Autoimmune and Inflammatory Conditions

Systemic lupus erythematosus (SLE), multiple sclerosis, celiac disease, and Sjögren's syndrome all produce cognitive symptoms through neuroinflammatory mechanisms. Celiac disease in particular is underdiagnosed: anti-tissue transglutaminase IgA (anti-tTG IgA) with total IgA is a simple and inexpensive screen.

Hashimoto's encephalopathy is a rare but treatable autoimmune encephalopathy that can present with cognitive symptoms and elevated anti-TPO antibodies even when thyroid function tests are normal.

Medications and Substances

Anticholinergic medications are among the most underrecognized pharmacological causes. The anticholinergic burden scale identifies drugs such as diphenhydramine, oxybutynin, tricyclic antidepressants, and certain antihistamines as contributing to cognitive impairment, particularly in adults over 50.

Benzodiazepines, cannabis (especially high-THC products), alcohol at even moderate chronic intake, and proton pump inhibitors (through B12 depletion) are other common culprits worth reviewing in any medication reconciliation.

How Brain Fog Is Diagnosed

History and Timeline

Onset, duration, triggers, and accompanying symptoms determine the most likely category. Gradual onset over months in a 48-year-old woman with irregular cycles is almost certainly perimenopausal. Sudden onset following a COVID-19 infection is long COVID until proven otherwise. Onset coinciding with starting a new medication is drug-induced until the drug is removed.

First-Line Laboratory Panel

A targeted first pass covers the most common and treatable causes:

• TSH, free T4, free T3
• CBC with differential
• Comprehensive metabolic panel
• Fasting glucose and HbA1c
• Fasting insulin (for HOMA-IR calculation)
• Vitamin B12 and folate
• 25-OH vitamin D
• Ferritin and serum iron
• CRP (high-sensitivity)
• Total and free testosterone (both sexes)
• Estradiol, FSH, LH (for perimenopausal/menopausal women or if hypogonadism is suspected)
• Lipid panel (hypercholesterolemia independently associates with cognitive slowing)

Second-Line Testing

If first-line labs are unrevealing, consider:

• Anti-tTG IgA with total IgA (celiac screen)
• Anti-TPO and anti-thyroglobulin antibodies
• ANA with reflex (for connective tissue disease)
• Homocysteine and methylmalonic acid (functional B12 status)
• Overnight oximetry or formal polysomnography (sleep apnea)
• Neuropsychological testing (objective cognitive assessment)

When Imaging Is Indicated

MRI of the brain is not a first-line test for brain fog in the absence of focal neurological signs, seizures, or rapid cognitive decline. The American Academy of Neurology does not recommend routine neuroimaging for isolated cognitive complaints in adults under 60 without accompanying red flags.

Red Flags That Require Urgent Evaluation

Some cognitive changes are not brain fog at all. The following warrant same-day or emergency assessment:

• Sudden-onset severe headache with confusion
• Fever, neck stiffness, or altered consciousness (meningitis/encephalitis)
• Focal weakness, aphasia, or visual field loss (stroke)
• Cognitive decline that is rapid and progressive over weeks (prion disease, autoimmune encephalitis)
• New confusion in a patient with known cancer (brain metastases, paraneoplastic syndrome)
• Confusion with asterixis or jaundice (hepatic encephalopathy)

Any of these presentations belong in an emergency department, not a telehealth queue.

Evidence-Based Treatments for Brain Fog by Cause

Sleep Optimization

Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment per the American Academy of Sleep Medicine, with remission rates of 50 to 60% at 6 months and durability superior to pharmacotherapy. For suspected OSA, CPAP therapy reduces daytime cognitive impairment within 4 weeks of adherence in most patients. [17]

Hormone Therapy

For menopausal women with cognitive symptoms, the Menopause Society 2023 position statement notes: "Hormone therapy initiated early in the menopause transition may have a beneficial effect on cognitive function." [9] The timing hypothesis matters: therapy started more than 10 years after menopause (or after age 60) does not carry the same cognitive benefit and may carry risk.

For hypogonadal men, testosterone replacement therapy (TRT) using testosterone cypionate 100 to 200 mg IM every 2 weeks or testosterone gel 1.62% daily is standard. Target total testosterone is 400 to 700 ng/dL per most endocrinology guidelines.

Thyroid Correction

Overt hypothyroidism (TSH >10 mIU/L or symptomatic with lower TSH) is treated with levothyroxine titrated to a TSH of 0.5 to 2.5 mIU/L for most patients under 60. Adding liothyronine (T3) to levothyroxine is not standard first-line therapy but may benefit a subset of patients with the DIO2 polymorphism, a topic of active research.

Nutritional Repletion

B12 deficiency responds to 1,000 mcg cyanocobalamin or methylcobalamin orally daily (or IM injections if GI absorption is impaired). Vitamin D insufficiency is treated with 2,000 to 5,000 IU daily cholecalciferol, aiming for serum 25-OH D of 40 to 60 ng/mL. Iron deficiency is addressed with ferrous sulfate 325 mg orally with vitamin C, though iron bisglycinate is better tolerated in patients with GI sensitivity.

Managing Long COVID Cognitive Symptoms

No FDA-approved pharmacotherapy exists specifically for long COVID brain fog. Low-dose naltrexone (LDN) at 1.5 to 4.5 mg nightly is used off-label and has shown modest benefit in small open-label studies through presumed microglial modulation. A phase 2 RCT of LDN for long COVID is ongoing at Stanford. Prioritizing sleep, treating any co-existing hypothyroidism or nutritional deficiencies, and avoiding cognitive overexertion remains the current evidence-based standard.

Depression and Anxiety Treatment

SSRIs and SNRIs remain first-line pharmacotherapy. Fluoxetine 20 mg, sertraline 50 mg, and escitalopram 10 mg are the most studied. For patients who prefer non-pharmacological options, meta-analyses confirm that structured exercise (150 minutes per week of moderate aerobic activity) reduces depressive symptoms comparably to SSRIs in mild-to-moderate MDD. [18]

The HealthRX Diagnostic Approach to Brain Fog

The HealthRX medical team uses a four-step triage sequence for patients presenting with brain fog:

1. Rule out red flags first. Sudden-onset or rapidly progressive cognitive change does not go through a telehealth workflow.
2. Order the first-line panel in a single draw. Waiting for TSH before checking testosterone wastes 2 to 4 weeks. Running the full panel at once allows pattern recognition: a perimenopausal woman with low estradiol, low ferritin, and vitamin D of 18 ng/mL has three simultaneous and correctable causes.
3. Revisit medications. Every anticholinergic, benzodiazepine, and PPI gets flagged before attributing symptoms to hormones.
4. Treat and reassess at 8 to 12 weeks. Cognitive response to hormone therapy, thyroid correction, or nutritional repletion takes 8 to 12 weeks to become subjectively and objectively measurable.

Frequently Asked Questions